-
Je něco špatně v tomto záznamu ?
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma
Dusan Klos, Jan Hanuliak, Radka Lemstrova, Beatrice Mohelnikova-Duchonova, Jana Zapletalova, Bohuslav Melichar, Juraj Risko
Status minimální Jazyk angličtina Země Slovensko
OBJECTIVES: The aim of this study is to evaluate the results of treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) at a single center. METHODS: We conducted a retrospective single-center observational cohort study of consecutive patients with DMPM treated by CRS-HIPEC at the Department of Surgery I of the University Hospital in Olomouc, Czech Republic. RESULTS: Data on a total of 16 patients were processed. The study group of 16 patients had six (37.5 %) women. The mean age was approximately 62 years. Complete cytoreduction was achieved in all patients (100 %) (CC0: 75 %, CC1: 25 %). All patients underwent a closed form of HIPEC with cisplatin and doxorubicin for 90 min. The mean hospital stay was 13.5 days, including 4.38 days in the ICU (13.5 ± 5.07 and 4.38 ± 1.49, respectively). Major postoperative complications (CD grades 3–4) occurred in four patients (25 %). In-hospital mortality was 6.25 %. In the study group, the median overall survival was 20 months, and the median disease-free survival was 10.3 months. CONCLUSIONS: Also under the conditions at our specialized center, CRS-HIPEC is considered as an effective, affordable, and safe therapy with OS, DFS, morbidity, and mortality rates comparable to those reported in the literature (Tab. 5, Fig. 2, Ref. 28).
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23023155
- 003
- CZ-PrNML
- 005
- 20240109151137.0
- 007
- ta
- 008
- 240109s2023 xo d f 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.4149/BLL_2023_052 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Klos, Dušan $7 xx0081738 $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 245 10
- $a Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma / $c Dusan Klos, Jan Hanuliak, Radka Lemstrova, Beatrice Mohelnikova-Duchonova, Jana Zapletalova, Bohuslav Melichar, Juraj Risko
- 504 __
- $a Literatura
- 520 9_
- $a OBJECTIVES: The aim of this study is to evaluate the results of treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) at a single center. METHODS: We conducted a retrospective single-center observational cohort study of consecutive patients with DMPM treated by CRS-HIPEC at the Department of Surgery I of the University Hospital in Olomouc, Czech Republic. RESULTS: Data on a total of 16 patients were processed. The study group of 16 patients had six (37.5 %) women. The mean age was approximately 62 years. Complete cytoreduction was achieved in all patients (100 %) (CC0: 75 %, CC1: 25 %). All patients underwent a closed form of HIPEC with cisplatin and doxorubicin for 90 min. The mean hospital stay was 13.5 days, including 4.38 days in the ICU (13.5 ± 5.07 and 4.38 ± 1.49, respectively). Major postoperative complications (CD grades 3–4) occurred in four patients (25 %). In-hospital mortality was 6.25 %. In the study group, the median overall survival was 20 months, and the median disease-free survival was 10.3 months. CONCLUSIONS: Also under the conditions at our specialized center, CRS-HIPEC is considered as an effective, affordable, and safe therapy with OS, DFS, morbidity, and mortality rates comparable to those reported in the literature (Tab. 5, Fig. 2, Ref. 28).
- 700 1_
- $a Hanuliak, Jan $7 xx0233032 $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Lemstrová, Radmila $7 xx0233024 $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Mohelníková-Duchoňová, Beatrice $7 xx0233023 $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Zapletalová, Jana, $d 1962- $7 xx0111614 $u Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Melichar, Bohuslav, $d 1965- $7 skuk0000853 $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Riško, Juraj $7 xx0233031 $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
- 773 0_
- $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 124, č. 5 (2023), s. 345-350 $w MED00000845
- 856 41
- $u http://www.elis.sk/download_file.php?product_id=7991&session_id=7cmce1hbsfsdgujb6b93572nv2 $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4 $c 1067 $y 0 $z 0
- 990 __
- $a 20240109132428 $b ABA008
- 991 __
- $a 20240109151134 $b ABA008
- 999 __
- $a min $b bmc $g 2033205 $s 1209606
- BAS __
- $a 3
- BMC __
- $a 2023 $b 124 $c 5 $d 345-350 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845 $n Bratisl Lek Listy
- LZP __
- $a NLK 2024-02/kv